Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
Thieme CJ, Blazquez-Navarro A, Safi L, Kaliszczyk S, Paniskaki K, Neumann IE, Schmidt K, Stockhausen M, Hörstrup J, Cinkilic O, Flitsch-Kiefner L, Meister TL, Marheinecke C, Pfaender S, Steinmann E, Seibert FS, Stervbo U, Westhoff TH, Roch T, Babel N. Thieme CJ, et al. Among authors: marheinecke c. J Am Soc Nephrol. 2021 Nov;32(11):2725-2727. doi: 10.1681/ASN.2021050672. J Am Soc Nephrol. 2021. PMID: 34716240 Free PMC article. No abstract available.
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients.
Blazquez-Navarro A, Safi L, Meister TL, Thieme CJ, Kaliszczyk S, Paniskaki K, Stockhausen M, Hörstrup J, Cinkilic O, Flitsch-Kiefner L, Marheinecke C, Steinmann E, Seibert FS, Stervbo U, Westhoff TH, Pfaender S, Roch T, Babel N. Blazquez-Navarro A, et al. Among authors: marheinecke c. Kidney Int. 2021 Sep;100(3):698-700. doi: 10.1016/j.kint.2021.07.006. Epub 2021 Jul 14. Kidney Int. 2021. PMID: 34273381 Free PMC article. No abstract available.
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.
Stervbo U, Blazquez-Navarro A, Blanco EV, Safi L, Meister TL, Paniskaki K, Stockhausen M, Marheinecke C, Zimmer G, Wellenkötter J, Giglio T, Arora P, Pöhlmann S, Hoffmann M, Seibert FS, Pfaender S, Roch T, Westhoff TH, Cinkilic O, Babel N. Stervbo U, et al. Among authors: marheinecke c. Kidney Int. 2021 Dec;100(6):1335-1337. doi: 10.1016/j.kint.2021.09.015. Epub 2021 Oct 4. Kidney Int. 2021. PMID: 34619233 Free PMC article. No abstract available.
Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.
Paniskaki K, Anft M, Meister TL, Marheinecke C, Pfaender S, Skrzypczyk S, Seibert FS, Thieme CJ, Konik MJ, Dolff S, Anastasiou O, Holzer B, Dittmer U, Queren C, Fricke L, Rohn H, Westhoff TH, Witzke O, Stervbo U, Roch T, Babel N. Paniskaki K, et al. Among authors: marheinecke c. Front Immunol. 2022 Jan 25;13:816220. doi: 10.3389/fimmu.2022.816220. eCollection 2022. Front Immunol. 2022. PMID: 35145522 Free PMC article.
In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
Heinen N, Marheinecke CS, Bessen C, Blazquez-Navarro A, Roch T, Stervbo U, Anft M, Plaza-Sirvent C, Busse S, Klöhn M, Schrader J, Vidal Blanco E, Urlaub D, Watzl C, Hoffmann M, Pöhlmann S, Tenbusch M, Steinmann E, Todt D, Hagenbeck C, Zimmer G, Schmidt WE, Quast DR, Babel N, Schmitz I, Pfänder S. Heinen N, et al. Among authors: marheinecke cs. Front Immunol. 2022 Dec 21;13:1062210. doi: 10.3389/fimmu.2022.1062210. eCollection 2022. Front Immunol. 2022. PMID: 36618413 Free PMC article.
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV.
Bessen C, Plaza-Sirvent C, Simsek A, Bhat J, Marheinecke C, Urlaub D, Bonowitz P, Busse S, Schumann S, Blanco EV, Skaletz-Rorowski A, Brockmeyer NH, Overheu O, Reinacher-Schick A, Faissner S, Watzl C, Pfaender S, Potthoff A, Schmitz I. Bessen C, et al. Among authors: marheinecke c. Front Immunol. 2022 Dec 2;13:1049070. doi: 10.3389/fimmu.2022.1049070. eCollection 2022. Front Immunol. 2022. PMID: 36532034 Free PMC article.
Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination.
Faissner S, Heitmann N, Rohling R, Ceylan U, Bongert M, Plaza-Sirvent C, Marheinecke C, Pedreiturria X, Ayzenberg I, Hellwig K, Schmitz I, Pfaender S, Gold R. Faissner S, et al. Among authors: marheinecke c. Ther Adv Neurol Disord. 2022 Dec 9;15:17562864221141505. doi: 10.1177/17562864221141505. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 36518553 Free PMC article.
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination.
Paniskaki K, Konik MJ, Anft M, Meister TL, Marheinecke C, Pfaender S, Jäger J, Krawczyk A, Zettler M, Dolff S, Westhoff TH, Rohn H, Stervbo U, Witzke O, Babel N. Paniskaki K, et al. Among authors: marheinecke c. Front Immunol. 2022 Oct 31;13:1031254. doi: 10.3389/fimmu.2022.1031254. eCollection 2022. Front Immunol. 2022. PMID: 36389833 Free PMC article.